Global Health Grants 10,000 Stock Options to Employee Under GHL LTIP 2024 Plan
Global Health Limited's Nomination and Remuneration Committee approved the grant of 10,000 Employee Stock Options to one employee under Part-A of the GHL LTIP 2024 Plan on May 11, 2026. The options are priced at Rs. 960/- each, with each option convertible into one equity share of Rs. 2/- face value, subject to a maximum vesting period of 5 years and an exercise window of 3 years from the date of vesting of the last instalment.
*this image is generated using AI for illustrative purposes only.
Global Health Limited's Nomination and Remuneration Committee, in its meeting held on May 11, 2026, approved the grant of 10,000 Employee Stock Options (ESOPs) to one employee under Part-A of the GHL Employee Long Term Share Based Incentive Plan 2024 (GHL LTIP 2024 Plan). The disclosure was made pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. The committee meeting commenced at 10:45 A.M. and concluded at 11:35 A.M. on the same day.
ESOP Grant Details
The grant forms part of the GHL Employees Stock Option Scheme, 2024, which is in compliance with the SEBI (Share Based Employee Benefits and Sweat Equity) Regulations, 2021. The key parameters of the current grant are outlined below:
| Parameter: | Details |
|---|---|
| Number of Options Granted: | 10,000 |
| Number of Employees Covered: | 1 |
| Exercise Price: | Rs. 960/- per option |
| Face Value per Equity Share: | Rs. 2/- each |
| Shares Arising per Option: | 1 equity share |
| Exercise Period: | Maximum 3 years from the date of vesting of last instalment |
| Vesting Period: | Maximum 5 years from the date of grant |
Scheme Objectives
The GHL LTIP 2024 Plan is designed as a long-term incentive tool to attract, retain, and motivate key talent within the organisation. The scheme aims to reward employees for their association, dedication, and contribution to the company's goals. By enabling employees to become co-owners through stock ownership, the plan seeks to align individual performance with overall corporate growth and profitability.
Key Terms and Conditions
The significant terms governing the current grant include the following:
- Exercise Period: Vested options are eligible for exercise on and from the date of vesting, within a maximum period of 3 years from the date of vesting of the last instalment of options under the scheme.
- Vesting Schedule: Options granted under the current tranche will vest in accordance with the vesting schedule and vesting conditions outlined in the grant letter, subject to a maximum vesting period of 5 years from the date of grant.
- Equity Conversion: Each option, upon exercise, will result in the allotment of one equity share of Rs. 2/- each.
The intimation was signed by Rahul Ranjan, Company Secretary and Compliance Officer of Global Health Limited, and submitted to both BSE Limited and the National Stock Exchange of India Limited as required under the listing regulations.
Historical Stock Returns for Global Health
| 1 Day | 5 Days | 1 Month | 6 Months | 1 Year | 5 Years |
|---|---|---|---|---|---|
| +3.29% | +4.55% | +16.39% | +2.80% | -0.50% | +197.47% |
How might the Rs. 960 exercise price compare to Global Health Limited's market price at vesting, and what does this imply for the employee's potential gains over the 5-year vesting period?
Will Global Health Limited expand its ESOP grants under the GHL LTIP 2024 Plan to a broader set of employees, and how could this impact the company's overall equity dilution?
How does Global Health Limited's ESOP strategy compare to peer healthcare companies in India in terms of attracting and retaining senior talent amid growing competition in the sector?
18
Create Custom Screeners 
Access 200+ Pre-built Filters 
Use 50+ Readymade Screener 
